AETHLON MEDICAL INC (AEMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue Quarterly

0 350K 700K 1.1M Q1 '12: 0 Q2 '12: 0 Q3 '12: 958.1K Q4 '12: 401.5K Q1 '13: 216.7K Q2 '13: 400.1K Q3 '13: 208.8K Q4 '13: 404.4K Q1 '14: 195.6K Q2 '14: 644.9K Q3 '14: 76.3K Q4 '14: 707K Q1 '15: 51.3K Q2 '15: 479.1K Q3 '15: 33.4K Q4 '15: 198.6K Q1 '17: 4.6K Q2 '17: 387.4K Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 74.8K Q4 '18: 74.8K Q1 '19: 149.6K Q2 '19: 0 Q3 '19: 0 Q4 '19: 80K Q1 '20: 30K Q2 '20: 0 Q3 '20: 413.5K Q4 '20: 206.7K Q1 '21: 0 Q2 '21: 0 Q3 '21: 624.9K Q4 '21: 34.2K Q1 '22: 132K Q2 '22: 132K Q3 '22: 17.1K Q4 '22: 13.1K Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 574.2K Q2 '12 Q4 '13 Q2 '15 Q4 '17 Q2 '19 Q4 '20 Q2 '22 Q4 '23

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '11: -1.2M Q2 '11: -1.4M Q3 '11: -1M Q4 '11: -938.4K Q1 '12: -1M Q2 '12: -883K Q3 '12: -341.3K Q4 '12: -857.6K Q1 '13: -990.8K Q2 '13: -799.8K Q3 '13: -936.8K Q4 '13: -846.9K Q1 '14: -783.8K Q2 '14: -229.8K Q3 '14: -1.2M Q4 '14: -810K Q1 '15: -1.2M Q2 '15: -601.2K Q3 '15: -1.1M Q4 '15: -1.1M Q1 '16: -1.1M Q2 '16: -1.1M Q3 '16: -1.1M Q4 '16: -1.1M Q1 '17: -1.1M Q2 '17: -2.2M Q3 '17: -1.2M Q4 '17: -1.5M Q1 '18: -1.2M Q2 '18: -1.2M Q3 '18: -1.2M Q4 '18: -1.3M Q1 '19: -1.1M Q2 '19: -1.3M Q3 '19: -2M Q4 '19: -1.6M Q1 '20: -1.6M Q2 '20: -1.7M Q3 '20: -876.4K Q4 '20: -1.8M Q1 '21: -1.4M Q2 '21: -1.8M Q3 '21: -2.4M Q4 '21: -2.3M Q1 '22: -2.1M Q2 '22: -2M Q3 '22: -2.5M Q4 '22: -3.8M Q1 '23: -2.9M Q2 '23: -3.7M Q3 '23: -2.8M Q4 '23: -2.5M Q1 '24: -3.4M Q2 '24: -3.2M Q3 '24: -3.6M Q4 '24: -2.5M Q1 '25: -2.6M Q2 '25: -2.9M Q3 '25: -1.8M Q4 '25: -2M Q1 '26: -1.8M Q2 '26: -1.5M Q3 '26: -2.1M Q4 '26: -1.9M Q1 '27: -1.6M Q2 '11 Q3 '13 Q4 '15 Q1 '18 Q2 '20 Q3 '22 Q4 '24 Q1 '27

Net Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '11: -3.5M Q2 '11: -2.7M Q3 '11: -1.9M Q4 '11: 2.4M Q1 '12: -2.6M Q2 '12: -453.5K Q3 '12: -574.7K Q4 '12: -4.5M Q1 '13: -1M Q2 '13: -1.4M Q3 '13: 313.9K Q4 '13: -2.8M Q1 '14: -303.5K Q2 '14: -3.3M Q3 '14: -2.2M Q4 '14: -7.5M Q1 '15: -3.7M Q2 '15: -847.4K Q3 '15: -1.6M Q4 '15: -886.7K Q1 '16: -1.2M Q2 '16: -1.2M Q3 '16: -1.2M Q4 '16: -1.2M Q1 '17: -2.1M Q2 '17: -2.3M Q3 '17: -1.2M Q4 '17: -1.7M Q1 '18: -1.8M Q2 '18: -1.3M Q3 '18: -1.2M Q4 '18: -1.3M Q1 '19: -1.1M Q2 '19: -1.4M Q3 '19: -2M Q4 '19: -1.6M Q1 '20: -2.1M Q2 '20: -1.7M Q3 '20: -819.6K Q4 '20: -1.8M Q1 '21: -1.4M Q2 '21: -1.8M Q3 '21: -2.4M Q4 '21: -2.3M Q1 '22: -2.1M Q2 '22: -2M Q3 '22: -2.5M Q4 '22: -3.8M Q1 '23: -2.9M Q2 '23: -3.8M Q3 '23: -2.8M Q4 '23: -2.5M Q1 '24: -3.3M Q2 '24: -3M Q3 '24: -3.5M Q4 '24: -2.4M Q1 '25: -2.6M Q2 '25: -2.8M Q3 '25: -1.8M Q4 '25: -6.3M Q1 '26: -1.8M Q2 '26: -1.5M Q3 '26: -2M Q4 '26: -1.9M Q1 '27: -1.5M Q2 '11 Q3 '13 Q4 '15 Q1 '18 Q2 '20 Q3 '22 Q4 '24 Q1 '27

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '11: -362.1K Q2 '11: -601.2K Q3 '11: -549.7K Q4 '11: -455.4K Q1 '12: -540.6K Q2 '12: -495.5K Q3 '12: -65K Q4 '12: -740.3K Q1 '13: -320.2K Q2 '13: -595.3K Q3 '13: -661.8K Q4 '13: -521.5K Q1 '14: -221.6K Q2 '14: -522.9K Q3 '14: -839.4K Q4 '14: -555.1K Q1 '15: -763.7K Q2 '15: -630.6K Q3 '15: -1.8M Q4 '15: -1.9M Q1 '16: -798K Q2 '16: -1.4M Q3 '16: -963.9K Q4 '16: -1.1M Q1 '17: -827.9K Q2 '17: -935.8K Q3 '17: -788.2K Q4 '17: -954K Q1 '18: -1.1M Q2 '18: -1M Q3 '18: -789.7K Q4 '18: -1M Q1 '19: -818.4K Q2 '19: -991.3K Q3 '19: -1.1M Q4 '19: -1.4M Q1 '20: -1.2M Q2 '20: -1.1M Q3 '20: -1.3M Q4 '20: -1.6M Q1 '21: -1.1M Q2 '21: -1.2M Q3 '21: -2.2M Q4 '21: -2.2M Q1 '22: -2.1M Q2 '22: -1.9M Q3 '22: -2.7M Q4 '22: -3.1M Q1 '23: -2.7M Q2 '23: -2.9M Q3 '23: -2M Q4 '23: -2.9M Q1 '24: -2.5M Q2 '24: -2.7M Q3 '24: -2.4M Q4 '24: -2.6M Q1 '25: -1.7M Q2 '25: -2.2M Q3 '25: -2M Q4 '25: -1.7M Q1 '26: -1.7M Q2 '26: -1.7M Q3 '26: -1.9M Q4 '26: -1.8M Q1 '27: -1.9M Q2 '11 Q3 '13 Q4 '15 Q1 '18 Q2 '20 Q3 '22 Q4 '24 Q1 '27

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '11: -363K Q2 '11: -601.2K Q3 '11: -551.4K Q4 '11: -455.4K Q1 '12: -542.3K Q2 '12: -495.5K Q3 '12: -65K Q4 '12: -740.3K Q3 '13: -661.8K Q4 '13: -521.5K Q3 '14: -900.8K Q4 '14: -589.7K Q1 '15: -763.7K Q2 '15: -630.6K Q3 '15: -1.8M Q4 '15: -1.9M Q1 '16: -798K Q2 '16: -1.4M Q3 '16: -973.2K Q4 '16: -1.1M Q1 '17: -829.5K Q2 '17: -937.2K Q3 '17: -788.2K Q4 '17: -967.4K Q1 '18: -1.1M Q2 '18: -1M Q3 '18: -789.7K Q4 '18: -1M Q1 '19: -818.4K Q2 '19: -991.3K Q3 '19: -1.1M Q4 '19: -1.4M Q1 '20: -1.2M Q2 '20: -1.2M Q3 '20: -1.3M Q4 '20: -1.6M Q1 '21: -1.1M Q2 '21: -1.2M Q3 '21: -2.2M Q4 '21: -2.2M Q1 '22: -2.1M Q2 '22: -1.9M Q3 '22: -2.8M Q4 '22: -3.3M Q1 '23: -2.8M Q2 '23: -3.6M Q3 '23: -2.1M Q4 '23: -3M Q1 '24: -2.7M Q2 '24: -2.7M Q3 '24: -2.4M Q4 '24: -2.6M Q1 '25: -1.7M Q2 '25: -2.2M Q3 '25: -2M Q4 '25: -1.7M Q1 '26: -1.7M Q1 '27: -1.9M Q2 '11 Q4 '13 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q1 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '11: 64.4M Q2 '11: 68.7M Q3 '11: 70.9M Q1 '12: 87.8M Q2 '12: 99.7M Q3 '12: 107.1M Q1 '13: 135.9M Q2 '13: 144.7M Q3 '13: 294.3M Q1 '14: 138.3M Q2 '14: 187.6M Q3 '14: 198.2M Q1 '15: 227.1M Q2 '15: 259.4M Q1 '22: 12.8M Q2 '22: 15.4M Q3 '22: 15.4M Q1 '23: 15.5M Q2 '23: 2.1M Q3 '23: 2.3M Q1 '24: 2.4M Q2 '24: 2.5M Q3 '24: 2.5M Q1 '25: 932.2K Q2 '25: 174.2K Q3 '25: 174.5K Q1 '26: 41.5K Q2 '26: 397.5K Q3 '26: 823.1K Q1 '27: 384.7K Q2 '11 Q3 '12 Q1 '14 Q2 '15 Q1 '23 Q2 '24 Q3 '25 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-120.00 -80.00 -40.00 0.00 40.00 80.00 120.00 Q4 '11: -0.08 Q1 '12: -0.06 Q2 '12: -0.02 Q3 '12: -0.00 Q4 '12: -0.08 Q1 '13: -0.06 Q2 '13: -0.07 Q3 '13: -0.06 Q4 '13: -0.04 Q1 '14: -0.03 Q2 '14: -0.04 Q3 '14: -0.05 Q4 '14: -3.44 Q2 '16: -0.70 Q3 '16: -0.60 Q4 '16: -0.66 Q1 '17: -0.76 Q2 '17: -0.89 Q3 '17: -0.88 Q4 '17: -0.94 Q1 '18: -0.87 Q2 '18: -0.72 Q3 '18: -0.65 Q4 '18: -0.10 Q1 '19: 0.05 Q2 '19: -0.98 Q3 '19: -2.57 Q4 '19: -4.21 Q1 '20: -5.78 Q2 '20: -5.90 Q3 '20: -4.51 Q4 '20: -1.87 Q1 '21: -0.39 Q2 '21: 0.75 Q3 '21: 0.83 Q4 '21: -0.65 Q1 '22: -0.66 Q2 '22: -0.64 Q3 '22: -0.60 Q4 '22: -0.70 Q1 '23: -0.73 Q2 '23: -2.44 Q3 '23: -3.52 Q4 '23: -4.29 Q1 '24: -5.45 Q2 '24: -4.83 Q3 '24: -4.96 Q4 '24: -38.86 Q1 '25: -40.27 Q2 '25: -55.16 Q3 '25: -63.84 Q4 '25: -66.34 Q1 '26: -106.00 Q2 '26: -93.63 Q3 '26: -86.03 Q1 '13 Q4 '14 Q4 '17 Q3 '19 Q2 '21 Q1 '23 Q4 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.